1. Home
  2. PII vs PBLS Comparison

PII vs PBLS Comparison

Compare PII & PBLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Polaris Inc.

PII

Polaris Inc.

HOLD

Current Price

$52.35

Market Cap

3.3B

ML Signal

HOLD

Logo Parabilis Medicines Inc. Common Stock

PBLS

Parabilis Medicines Inc. Common Stock

N/A

Current Price

$31.46

Market Cap

3.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PII
PBLS
Founded
1954
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
3.6B
IPO Year
1994
2026

Fundamental Metrics

Financial Performance
Metric
PII
PBLS
Price
$52.35
$31.46
Analyst Decision
Hold
Analyst Count
11
0
Target Price
★ $62.27
N/A
AVG Volume (30 Days)
★ 715.6K
707.2K
Earning Date
04-27-2026
N/A
Dividend Yield
★ 4.05%
N/A
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
★ $7,152,000,000.00
N/A
Revenue This Year
$1.20
N/A
Revenue Next Year
$4.51
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$47.14
$25.56
52 Week High
$77.98
$42.49

Technical Indicators

Market Signals
Indicator
PII
PBLS
Relative Strength Index (RSI) 27.71 37.75
Support Level $52.22 $26.42
Resistance Level $74.00 $33.65
Average True Range (ATR) 1.94 3.26
MACD -0.14 -0.93
Stochastic Oscillator 9.32 14.63

Price Performance

Historical Comparison
PII
PBLS

About PII Polaris Inc.

Polaris designs and manufactures off-road vehicles, including all-terrain vehicles and side-by-side vehicles for recreational, utility, military, and commercial purposes, snowmobiles, and on-road vehicles, along with the related replacement parts, garments, and accessories. The firm entered the marine market after acquiring Boat Holdings in 2018, offering exposure to pontoon and deck boat users. It is slated to divest its Indian motorcycle brand to Carolwood in the first quarter of 2026. Polaris products are retailed through more than 2,500 dealers in North America and 1,500 international dealers as well as more than 25 subsidiaries and 90 distributors in more than 100 countries outside North America.

About PBLS Parabilis Medicines Inc. Common Stock

Parabilis Medicines Inc s a clinical-stage biopharmaceutical company. It is focused on the development of medicines targeting protein interactions associated with human diseases. It uses a proprietary platform to develop stabilized helical peptide therapeutics, referred to as Helicons, designed to bind and modulate specific proteins. Its flagship product candidate, zolucatetide, targets the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors within the Wnt/β-catenin signaling pathway, which is associated with cell proliferation and differentiation in multiple cancer types.

Share on Social Networks: